Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis.
Evrenkaya
T Rifki
TR
Atasoyu
Enes M
EM
Unver
Suat
S
Basekim
Cinar
C
Baloglu
Huseyin
H
Tulbek
M Yasar
MY
D000438:Alcohols / Q000009:adverse effects; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002710:Chlorhexidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003902:Detergents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000295:instrumentation*; D010538:Peritonitis; D011239:Prednisolone; D012598:Sclerosis; D013629:Tamoxifen
D000438:Alcohols; D003902:Detergents; D007166:Immunosuppressive Agents; D013629:Tamoxifen; D011239:Prednisolone; C010882:chlorhexidine gluconate; D002710:Chlorhexidine